API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
0
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
89
PharmaCompass offers a list of Pyridostigmine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Pyridostigmine manufacturer or Pyridostigmine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Pyridostigmine manufacturer or Pyridostigmine supplier.
PharmaCompass also assists you with knowing the Pyridostigmine API Price utilized in the formulation of products. Pyridostigmine API Price is not always fixed or binding as the Pyridostigmine Price is obtained through a variety of data sources. The Pyridostigmine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Pyridostigmine Bromide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Pyridostigmine Bromide, including repackagers and relabelers. The FDA regulates Pyridostigmine Bromide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Pyridostigmine Bromide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Pyridostigmine Bromide manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Pyridostigmine Bromide supplier is an individual or a company that provides Pyridostigmine Bromide active pharmaceutical ingredient (API) or Pyridostigmine Bromide finished formulations upon request. The Pyridostigmine Bromide suppliers may include Pyridostigmine Bromide API manufacturers, exporters, distributors and traders.
click here to find a list of Pyridostigmine Bromide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Pyridostigmine Bromide DMF (Drug Master File) is a document detailing the whole manufacturing process of Pyridostigmine Bromide active pharmaceutical ingredient (API) in detail. Different forms of Pyridostigmine Bromide DMFs exist exist since differing nations have different regulations, such as Pyridostigmine Bromide USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Pyridostigmine Bromide DMF submitted to regulatory agencies in the US is known as a USDMF. Pyridostigmine Bromide USDMF includes data on Pyridostigmine Bromide's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Pyridostigmine Bromide USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Pyridostigmine Bromide suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Pyridostigmine Bromide Drug Master File in Japan (Pyridostigmine Bromide JDMF) empowers Pyridostigmine Bromide API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Pyridostigmine Bromide JDMF during the approval evaluation for pharmaceutical products. At the time of Pyridostigmine Bromide JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Pyridostigmine Bromide suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Pyridostigmine Bromide Drug Master File in Korea (Pyridostigmine Bromide KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Pyridostigmine Bromide. The MFDS reviews the Pyridostigmine Bromide KDMF as part of the drug registration process and uses the information provided in the Pyridostigmine Bromide KDMF to evaluate the safety and efficacy of the drug.
After submitting a Pyridostigmine Bromide KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Pyridostigmine Bromide API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Pyridostigmine Bromide suppliers with KDMF on PharmaCompass.
A Pyridostigmine Bromide CEP of the European Pharmacopoeia monograph is often referred to as a Pyridostigmine Bromide Certificate of Suitability (COS). The purpose of a Pyridostigmine Bromide CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Pyridostigmine Bromide EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Pyridostigmine Bromide to their clients by showing that a Pyridostigmine Bromide CEP has been issued for it. The manufacturer submits a Pyridostigmine Bromide CEP (COS) as part of the market authorization procedure, and it takes on the role of a Pyridostigmine Bromide CEP holder for the record. Additionally, the data presented in the Pyridostigmine Bromide CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Pyridostigmine Bromide DMF.
A Pyridostigmine Bromide CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Pyridostigmine Bromide CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Pyridostigmine Bromide suppliers with CEP (COS) on PharmaCompass.
A Pyridostigmine Bromide written confirmation (Pyridostigmine Bromide WC) is an official document issued by a regulatory agency to a Pyridostigmine Bromide manufacturer, verifying that the manufacturing facility of a Pyridostigmine Bromide active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Pyridostigmine Bromide APIs or Pyridostigmine Bromide finished pharmaceutical products to another nation, regulatory agencies frequently require a Pyridostigmine Bromide WC (written confirmation) as part of the regulatory process.
click here to find a list of Pyridostigmine Bromide suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Pyridostigmine Bromide as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Pyridostigmine Bromide API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Pyridostigmine Bromide as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Pyridostigmine Bromide and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Pyridostigmine Bromide NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Pyridostigmine Bromide suppliers with NDC on PharmaCompass.
Pyridostigmine Bromide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Pyridostigmine Bromide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Pyridostigmine Bromide GMP manufacturer or Pyridostigmine Bromide GMP API supplier for your needs.
A Pyridostigmine Bromide CoA (Certificate of Analysis) is a formal document that attests to Pyridostigmine Bromide's compliance with Pyridostigmine Bromide specifications and serves as a tool for batch-level quality control.
Pyridostigmine Bromide CoA mostly includes findings from lab analyses of a specific batch. For each Pyridostigmine Bromide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Pyridostigmine Bromide may be tested according to a variety of international standards, such as European Pharmacopoeia (Pyridostigmine Bromide EP), Pyridostigmine Bromide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Pyridostigmine Bromide USP).